BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Drug Product News
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States 7/24/2014
Abbott Introduces New Similac® Breastfeeding Supplement With DHA, Lutein And Vitamin E 7/24/2014
Boehringer Ingelheim Corporation Release: Benefits And Safety Of Pradaxa® (Dabigatran Etexilate Mesylate) Repeatedly Confirmed 7/24/2014
Daiichi Sankyo, Inc. (4568.t) And Eli Lilly and Company (LLY): Heart Patients In England And Wales Offered More Choice Of Therapies As National Institute for Clinical Excellence (NICE) Extends Recommendations For Prasugrel 7/23/2014
Sanofi Pasteur (SASY.PA) Begins Shipping Seasonal Influenza Vaccine For Upcoming 2014-2015 Season In United States 7/22/2014
BioTie Therapies Corp.: Selincro Enters The Market In Spain 7/22/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
Third Product In Vernalis PLC (VNLPY.PK)’ Cough Cold Pipeline (CCP-08) Achieves Proof-Of-Concept 7/22/2014
Shire Release: Firazyr®: First Subcutaneous Treatment For Acute Attacks Of Rare And Serious Swelling Disorder Now Available In Canada 7/21/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
BioAlliance Pharma Announces The Launch Of Sitavig® In The United States By Its Partner Innocutis 7/21/2014
Durata Therapeutics, Inc.  (DRTX) Announces The U.S. Launch Of Dalvance™ 7/18/2014
MediGene AG (MDGEF.PK)'s Drug Veregen® Launched In Canada 7/17/2014
NovaBay Pharmaceuticals, Inc. (NBY) Announces Direct US Marketing-Sales Campaign For New i-Lid™ Cleanser Product 7/16/2014
Bial And moksha8 Announce Exclusive License For The Commercialization Of Eslicarbazepine Acetate (Zebinix® / Exalief®) In Brazil And Mexico 7/15/2014
Celsion Corporation (CLN) Announces Commercialization Of Reagent Products 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
Upsher-Smith Laboratories Announces Immediate Availability Of A Generic Equivalent To Qudexy™ XR (Topiramate) Extended-Release Capsules 7/14/2014
Kaleo Release: EVZIO™ (naloxone HCl injection) Auto-Injector Now Available In The United States For The Emergency Treatment Of Opioid Overdose 7/10/2014
The International Myeloma Foundation Says IMNOVID® (Pomalidomide), The Newest Medication For Advanced Cases Of Multiple Myeloma, Is Approved For Reimbursement In Sweden, Spain, And Switzerland 7/10/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014
BioTie Therapies Corp.: Selincro Receives Positive Draft Guidance From UK's National Institute for Clinical Excellence (NICE) 7/10/2014
PTC Therapeutics, Inc. (PTCT) Announces Expanded Access Program For Translarna™ (ataluren) 7/9/2014
Insight Pharmaceuticals Release: MONISTAT® Announces New Suite Of Complete Care™ Products 7/9/2014
Par Pharmaceutical, Inc. Begins Shipment Of Fluphenazine Decanoate Injection, USP 7/9/2014
Skystar Bio-Pharmaceutical (CGPN) Launches Bovine Immunoglobulin G (IgG) Kits In China 7/8/2014
Perrigo Company (PRGO) Announces FDA Final Approval For The Store Brand Equivalent To Advil® Congestion Relief Tablets, 200 mg/10 mg 7/8/2014
Mylan Inc. (MYL) Launches Generic Micardis® Tablets 7/8/2014
Novartis AG (NVS) Unveils Stronger Drug In Bid To Boost Malaria Treatment 7/7/2014
Tianyin Pharmaceutical Co, Inc. Receives GMP For Tablets Formulation In Early July 7/7/2014
Novartis AG (NVS) Begins Shipment Of Seasonal Influenza Vaccines To US Market For The 2014-2015 Season 7/3/2014
Upsher-Smith Laboratories Announces Launch Of The First And Only Generic Transdermal Testosterone Gel Available In Three Convenient Configurations 7/2/2014
NPS Pharmaceuticals, Inc. (NPSP) Release: FDA Approves Updated Labeling For Gattex® (Teduglutide [RDNA Origin]) For Injection To Include Long-Term Data 6/30/2014
Aqua Pharmaceuticals Announces Launch Of Cordran® Ointment (Flurandrenolide Ointment, USP) 0.05% 6/30/2014
Upsher-Smith Laboratories Launches Qudexy™ XR (Topiramate) Extended-Release Capsules For Treatment Of Specific Seizure Types 6/30/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Duloxetine Delayed-Release Capsules USP 6/27/2014
Ohm Laboratories, Inc. To Launch Valsartan Tablets 6/27/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Paricalcitol Capsules 6/25/2014
Quest Products, Inc. Introduces New ProVent® Eczema And Psoriasis Spray® 6/25/2014
Hetero Launches Darbepoetin Alfa, A Much Needed Biosimilar Anemia Treatment In India 6/19/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Release: AMITIZA® (Lubiprostone) Receives National Institute for Clinical Excellence (NICE) Recommendation 6/18/2014
Manzo Pharmaceuticals Announces The Release Of Its Newest Product Tummy Relief A Natural Colic Remedy For Babies 6/18/2014
UK's Cost Agency Not Ready To Back Gilead Sciences, Inc. (GILD)'s Controversial Hepatitis C Drug 6/17/2014
DermWorx Incorporated / LETI Laboratories S.L. To Launch Leading Atopic Skincare Line To The U.S. Market 6/17/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: ENTYVIO™ (vedolizumab) Now Available In The United States For The Treatment Of Adults With Moderately To Severely Active Ulcerative Colitis And Crohn's Disease 6/16/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In The United Kingdom 6/16/2014
Cepheid (CPHD) Announces European Release Of Xpert Carba-R, A Molecular Test For Rapid And Accurate Detection Of Carbapenemase-Producing Gram-Negative Bacteria 6/16/2014
Italy To Fund Unapproved Use Of Roche (RHHBY) Drug To Cut Costs; Move Startles The Industry 6/13/2014
MediGene AG (MDGEF.PK) Announces Market Launch Of Veregen®: In Belgium, Denmark And Finland 6/12/2014
Mylan Inc. (MYL) Launches Generic Actonel® Tablets, 150 mg 6/11/2014
Auxilium Pharmaceuticals (AUXL) Announces Launch Of Authorized Generic Version Of Testim (Testosterone Gel) 6/11/2014
Forest Laboratories, Inc. (FRX) Announces Intention To Continue Marketing Both NAMENDA® TABLETS And Once-Daily NAMENDA XR® Into The Fall Of 2014 6/11/2014
Medivir AB (MVRBF) Release: OLYSIO™ Available Soon In All Nordic Countries For The Treatment Of Adults With Hepatitis C Genotype 1 And 4 Infection 6/10/2014
Mylan Inc. (MYL) Launches Generic Paraplatin® Injection 6/9/2014
Both Are Roche (RHHBY)'s Drugs, But Which One Could Save The U.S. $3 Billion? 6/5/2014
Paragon BioTeck Announces FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available 6/4/2014
CorePharma LLC Announces The Launch Of Dextroamphetamine Sulfate Tablets, USP 6/4/2014
Norgen Biotek Corporation Launches 6 Novel Kits For The Isolation Of High-Quality Circulating Nucleic Acids From Blood, Plasma, Serum And Urine 6/4/2014
H2-Pharma Launches Authorized Generic LIPOFEN 6/3/2014
Gilead Sciences Canada, Inc. (GILD) Release: Quebec Becomes First Province To Reimburse Sovaldi® For The Treatment Of Chronic Hepatitis C 6/3/2014
Mission Pharmacal Company Begins Exclusive Promotion Of Elestrin® (Estradiol Gel) 0.06% In The U.S. Market 5/30/2014
Mylan Inc. (MYL) Launches Generic Malarone® Tablets 5/29/2014
Polyplus Transfection Launches A New Transfection Reagent For Bioproduction 5/28/2014
Genzyme Corporation (GENZ)'s Lemtrada Recommended For Reimbursement On NHS By The National Institute for Clinical Excellence (NICE) 5/28/2014
Pfizer Inc. (PFE) Brings Frequent Heartburn Relief Over-The-Counter With New Nexium® 24HR 5/27/2014
Solara Labs Announces The Launch Of BariMelts® 5/27/2014
ULURU Inc. Announces Shipments Of Altrazeal® To Italy, Spain And Portugal 5/27/2014
DiscoveRx Corporation Enables Predictive In Vitro Drug Combination Studies With Launch Of Biomap® Combo ELECT 5/21/2014
TOLMAR Pharmaceuticals Established To Market ELIGARD For Advanced Prostate Cancer In The U.S. And Puerto Rico 5/16/2014
ALK-Abello A/S's Partner For North America, Merck & Co., Inc. (MRK), Announces Launch Of RAGWITEK™ In Canada 5/15/2014
Negative National Institute for Clinical Excellence (NICE) Draft Guidance On Janssen Biotech Inc. (JNJ)'s Zytiga For Prostate Cancer 5/14/2014
Mylan Inc. (MYL) Launches Generic Zyprexa Zydis® Tablets 5/14/2014
INSYS Therapeutics Issues Clarifying Statement 5/13/2014
Veracyte, Inc. (VCYT) Launches Afirma® Malignancy Classifiers To Further Help Thyroid Nodule Patients Avoid Unnecessary Surgeries And Lower Healthcare Costs 5/13/2014
Ipsen (IPN.PA) Announces A Step Forward In The Resupply Of Increlex® (Mecasermin [rDNA Origin] Injection) In The U.S. 5/13/2014
Ajanta Pharma Announces The Launch Of Risperidone Tablets 5/9/2014
CorePharma LLC Launches Methylphenidate Hydrochloride Tablets USP 5/8/2014
Actavis (ACT) Launches Generic Version Of Catapres-TTS® 5/8/2014
Cumberland Pharmaceuticals (CPIX) Launches Vaprisol® Promotion 5/7/2014
Greer Labs Launches ORALAIR®, The First And Only Sublingual Allergy Immunotherapy Tablet With A Mix Of Five Grass Allergens For The Treatment Of Grass Pollen Allergy 5/5/2014
Otsuka Pharmaceutical Co., Ltd. Release: New Once-Monthly Treatment For Schizophrenia, ABILIFY MAINTENA™ (Aripiprazole For Prolonged Release Injectable Suspension), Now Available In Canada 5/5/2014
Covance Inc. (CVD) Launches New Brand: Solutions Made Real™ 5/2/2014
Access Pharmaceuticals (ACCP) MuGard Selected For Cover Article In The Print Edition Of The Journal Cancer 5/1/2014
MyoScience Inc. Release: Novel Pain Treatment Is Now Available: Iovera System Harnesses The Power Of Cold To Block Pain 5/1/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In The Nordic Countries 5/1/2014
Gilead Sciences, Inc. (GILD)'s Solvadi Strikes Again: $1,000 A Pill Rattles Medicaid Programs 4/30/2014
Medivir AB (MVRBF) Release: Adasuve Will Now Be Launched In Sweden, Norway, Finland, And Denmark 4/30/2014
GlaxoSmithKline (GSK)/Theravance, Inc. (THRX) Release: Anoro™ Ellipta® Now Available In The U.S. For Treatment Of COPD 4/28/2014
Heat On Roche (RHHBY) To Cut Kadcyla Price After National Institute for Clinical Excellence (NICE) Says "No" 4/23/2014
PuriCore Launches NovaZo Wound Hydrogel For Equine And Companion Animals 4/23/2014
NovaBay Pharmaceuticals, Inc. (NBY) Introduces Advanced I-Lid Cleanser For Cleaning Eyelids And Skin Around The Eye 4/23/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Initiation Of An Expanded Access Program To Provide Firdapse At No Cost To U.S. Patients With Lambert-Eaton Myasthenic Syndrome 4/23/2014
Zogenix, Inc. (ZGNX) Responds To Governor's Action Singling Out Zohydro™ ER In Massachusetts, Encourages Officials To Consider Patient Needs And Effective Class-Wide Measures 4/23/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Fenofibrate Capsules, USP 43 Mg And 130 Mg 4/23/2014
Oculus Innovative Sciences, Inc. (OCLS)' Partner, More Pharma Corporation, Launches Microcyn®-Based Oral And Throat Infection Treatment Product In Mexico 4/22/2014
Sagent Pharmaceuticals, Inc. Announces The Reintroduction Of Adenosine Injection, USP 4/21/2014
Stolen Roche (RHHBY) Cancer Drug Found On Market 4/18/2014
Mylan Inc. (MYL) Launches First Generic ORTHO EVRA® Patch 4/17/2014
Dr. Reddy's Laboratories Ltd. (RDY)’ Announces The Launch Of Eszopiclone Tablets C-IV 4/16/2014
IMPAX Laboratories, Inc. (IPXL) Launches Authorized Generic RENVELA® 4/16/2014
Apricus Biosciences (APRI)' Partner In The United Kingdom Accepts First Shipment Of Vitaros® 4/16/2014
Anika Therapeutics (ANIK) Announces First U.S. Commercial Sale Of Monovisc® 4/16/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Lunesta® Tablets In The United States 4/15/2014
Ferring Pharmaceuticals Release: UK National Institute for Clinical Excellence (NICE) Guidance Recommends FIRMAGON® (Degarelix) For The Treatment Of Advanced Hormone-Dependent Prostate Cancer Only In People With Spinal Metastases Who Present With Signs Or Symptoms Of Impending Spinal Cord Compression (ISCC) 4/15/2014
FDA Extends Market Exclusivity Six Months For BioMarin Pharmaceutical Inc. (BMRN)'s Rare Disease Therapy KUVAN® (Sapropterin Dihydrochloride) Powder For Oral Solution And Tablets 4/14/2014
Doctors Welcome Hepatitis C Drug Rivals, Gilead Sciences, Inc. (GILD) Still Leads 4/11/2014
Ironwood Pharmaceuticals (IRWD) And Forest Laboratories, Inc. (FRX) Launch New Direct-To-Consumer Awareness Campaign For LINZESS® 4/10/2014
AbbVie (ABBV) Announces Availability Of New Advanced Parkinson's Treatment In Canada 4/10/2014
Vanda Pharmaceuticals, Inc. (VNDA) Announces Availability of HETLIOZ™ (tasimelteon) For Non-24-Hour Sleep-Wake Disorder (Non-24) 4/10/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Plans To Gradually Phase-Out Of Ranbaxy Laboratories (RANBAXY.BO)-Branded Drugs In U.S. 4/9/2014
Pharmacy Benefit Manager Express Scripts Inc. Enraged, Looks To Force Gilead Sciences, Inc. (GILD) To Cut Price Of Sovaldi 4/9/2014
Sunovion Pharmaceuticals Inc. Release: Once-Daily Aptiom® (Eslicarbazepine Acetate) For The Adjunctive Treatment Of Partial-Onset Seizures Now Available In U.S. Pharmacies 4/7/2014
ULURU Inc. Release: Initial Pharmacoeconomic Data Demonstrates Cost Benefits Of Altrazeal® 4/7/2014
Swedish Orphan Biovitrum Becomes Market Authorisation Holder For Xiapex In Europe 4/7/2014
Zogenix, Inc. (ZGNX) Statement: Let's Get The Facts Straight About Zohydro ER 4/3/2014
Aerocrine Release: National Institute for Clinical Excellence (NICE) Recommends The Use Of Exhaled Nitric Oxide (Feno) Testing To Help Diagnose And Manage Asthma 4/2/2014
Swedish Orphan Biovitrum Assumes Direct Responsibility For Orfadin® (Nitisinone) In U.S. And Canada And Introduces Orfadin4U™ 4/1/2014
Sagent Pharmaceuticals, Inc. Announces The Launch Of Adenosine Injection, USP 3/31/2014
Mission Pharmacal Company Introduces New And Improved Version Of Top-Selling Prescription Prenatal Vitamin, Citranatal Harmony® 3/28/2014
Genzyme Corporation (GENZ) Release: U.S. Prescribing Information For Thyrogen Revised To Include Use Of Wider Range Of Radioiodine In Patients 3/27/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Amlodipine Besylate And Atorvastatin Calcium Tablets 3/27/2014
Gilead Sciences, Inc. (GILD)'s $84,000 Treatment Questioned By U.S. Lawmakers 3/25/2014
Sanofi (France) (SAN.PA) Release: National Institute for Clinical Excellence (NICE) Rejects Life-Extending Bowel Cancer Drug Two Weeks After Scottish Approval 3/25/2014
UK Cost Agency Says "No" To Bayer AG (BAYN.DE) Prostate Cancer Drug Xofigo 3/24/2014
UK Cancer Drugs Fund Adds Roche (RHHBY), Celgene Corporation (CELG) And Exelixis, Inc. (EXEL) Drugs 3/24/2014
Quinnova Pharmaceuticals, Inc. Announces The Launch Of ECOZA™ (Econazole Nitrate) Topical Foam, 1% 3/18/2014
National Institute of Clinical Research Turns Down Celgene (CELG)'s Revlimid 3/17/2014
NicOx SA (COX.PA) Launches Adenoplus® And Xailin™ Dry Eye Product Range In Europe 3/17/2014
H. Lundbeck A/S (LUN.CO) And Otsuka Pharmaceutical Co., Ltd. Initiate European Launch Of Abilify Maintena® (Aripiprazole), A Once-Monthly Formulation For The Treatment Of Schizophrenia 3/17/2014
FDA Commissioner Defends Zogenix, Inc. (ZGNX)'s Pain Drug As Criticism Intensifies 3/14/2014
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Announce The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In Romania 3/14/2014
Roche (RHHBY) And Jiangsu Province Bring Down High Cost Of Breast Cancer Drug 3/13/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Receives Notice That Second Indication For AMITIZA For Opioid-Induced Constipation Is Not Approved By Medicines And Healthcare Products Regulatory Agency In U.K. 3/13/2014
Bacterin International, Inc. Announces The Launch Of OsteoSTX, A Novel Biologic Product 3/13/2014
French Competition Regulator Probes Roche (RHHBY), Novartis AG (NVS) 3/12/2014
Perrigo Company (PRGO) Announces Launch Of Generic Version Of Neptazane™ (Methazolamide) Tablets 3/12/2014
Bayer HealthCare (BAY) Launches Eight New Products To Treat Flea And Tick Infestations 3/12/2014
Mylan Inc. (MYL) Launches Naloxone Hydrochloride Injection 3/12/2014
Antares Pharma, Inc. (ATRS) Announces LEO Pharma’s Launch Of OTREXUP (Methotrexate) Injection To Dermatologists For Adults With Psoriasis 3/10/2014
Novartis AG (NVS) Muscle Drug Sales May Reach $4 Billion, According To MorphoSys AG 3/7/2014
McNeil Consumer Healthcare Release: The Makers of ZYRTEC® Launch New Dissolve Tabs 3/6/2014
British Watchdog Wants U.S. Biotech Alexion Pharmaceuticals Inc. (ALXN) To Justify Cost Of Drug 3/5/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Moxifloxacin Hydrochloride Tablets 3/5/2014
Citron Research Says Prized Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Drug Missing Key Ingredient 3/4/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The U.S. Commercial Launch Of ADASUVE® By Teva Pharmaceutical Industries Limited (TEVA) 3/3/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches ADASUVE® In U.S. 3/3/2014
Dendreon Corporation (DNDN) Announces Plans To Make PROVENGE® Commercially Available In Europe 3/3/2014
Bayer AG (BAYN.DE) Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs 2/28/2014
Groups Urge FDA To Halt Launch Of Zogenix, Inc. (ZGNX)'s Zohydro Pain Drug 2/28/2014
Easton Pharmaceuticals (OP: EAPH) Announces The Launching Of Hempstral SA, A New Hemp Based Anti Ageing Product & Reaches Marketing Develop And Distribution Agreement With Hemplifetoday.Com 2/28/2014
Cell Therapeutics, Inc. (CTIC) Release: National Institute for Clinical Excellence (NICE) Publishes Final Guidance On PIXUVRI® (pixantrone) 2/27/2014
Records Show Boehringer Ingelheim Corporation Did Not Disclose Pradaxa Analysis To FDA 2/26/2014
Novartis Pharmaceuticals Canada Inc. (NVS) Release: Bexsero®: First Vaccine To Prevent Meningococcal Serogroup B (MenB) Now Available In Canada 2/26/2014
Essex Medipharma To Distribute Pfizer Inc. (PFE) Glaucoma Eye Drops In China 2/25/2014
National Institute for Clinical Excellence (NICE) Turns Down Biogen Idec, Inc. (Massachusetts) (BIIB)'s Oral MS Drug 2/24/2014
Gilead Sciences, Inc. (GILD) Close To Dominating Second Multibillion Market With Solvadi 2/24/2014
Forest Laboratories, Inc. (FRX) Launches STRIDE Patient Support Program For COPD Franchise Products Tudorza® Pressair® And Daliresp® 2/24/2014
Fresenius Kabi AG Release: Acetylcysteine Solution, USP 20% In 4 ML Vials Now Available 2/24/2014
Amarin Corporation PLC (AMRN) Announces FDA Award Of Three-Year Exclusivity For Vascepa® (Icosapent Ethyl) Capsules 2/24/2014
Afaxys Pharmaceuticals Release: Aubra™ Coverage Expands Significantly 2/21/2014
Innovus Pharma Announces Availability Of Ejectdelay™ For Premature Ejaculation In The United States 2/21/2014
Axxess Pharma, Inc. Announces Launch Of US TapouT Sales: Initial PO Through NPI, Nutritional Products International, A Leading Brand Management Company 2/18/2014
Double-Crane Pharmaceutical Co., Ltd. To Distribute Sagent Pharmaceuticals, Inc. Pediatric Drug In China 2/14/2014
Alvogen Launches Inflectra In Europe With Hospira, Inc. 2/13/2014
Gilead Sciences, Inc. (GILD) COO: Analysts' Sky-High Hep C Drug View "Not Unreasonable" 2/12/2014
Jazz Pharmaceuticals plc (JAZZ) Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension 2/12/2014
FDA Panel Votes Down Heart Safety Claim For Aleve 2/11/2014
Zogenix, Inc. Provides Update On Zohydro™ ER (Hydrocodone Bitartrate) Launch Readiness Plans 2/11/2014
FDA Panel To Weigh Painkiller' Cardiac Risk 2/10/2014
Arena Pharmaceuticals, Inc. (ARNA) Reports Coverage For BELVIQ® (Lorcaserin Hcl) CIV Now Greater Than 50% Of Insured Commercial Lives 2/10/2014
Eisai Inc. (ESALF.PK) Reports Improved Patient Access For BELVIQ® (lorcaserin HCI) CIV 2/10/2014
Mallinckrodt Pharmaceuticals (MNK)’ New Drug Available To Patients 2/10/2014
Nuvo Research Inc. (NRI.TO) Announces The U.S. Commercial Launch Of PENNSAID® 2% By Mallinckrodt Pharmaceuticals (MNK) 2/10/2014
pSivida Corp (PSDV) Announces ILUVIEN® For DME Accepted By National Health Service Scotland 2/10/2014
Covis Pharmaceuticals Announces Its New Expanded Dosage Options Of LANOXIN® For Cardiac Patients With Mild-To-Moderate Heart Failure 2/7/2014
All Physicians In Switzerland Are Now Able To Prescribe Sucampo Pharmaceuticals, Inc. (SCMP)'s AMITIZA® For Chronic Idiopathic Constipation 2/6/2014
Sanofi (France) (SAN.PA)'s Consumer Healthcare Division Chattem Announces Nasacort® Allergy 24HR Nasal Spray Now Available Without A Prescription In The U.S. 2/4/2014
Mylan Inc. (MYL) Launches First Trastuzumab Biosimilar, Hertraz™, In India 2/3/2014
Gilead Sciences, Inc. (GILD)'s $84,000 Hepatitis C Drug Sets Off Payer Revolt 1/30/2014
Bayer HealthCare (BAY)'s Annihilator™ Polyzone® Makes Insect Control Easy All Season Long 1/29/2014
Mylan Inc. (MYL) Launches Generic Prandin® Tablets 1/24/2014
Takeda Pharmaceuticals And Lundbeck Inc. (LUN.CO) Announce Brintellix® (Vortioxetine) For The Treatment Of Major Depressive Disorder In Adults Is Now Available In Pharmacies 1/23/2014
Avion Pharmaceuticals Announces The Launch Of Prenate® Enhance And Prenate® Restore 1/23/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces Grupo Ferrer Internacional S.A.'s Launch Of ADASUVE® (Staccato® Loxapine) In Spain Triggering A $1 Million Milestone Payment 1/23/2014
Eisai Company, Ltd. (ESALY.PK) Announces Launch Of New "Crystal Veil Mask Bokin 24 Mint" Face Mask Spray Containing Long-Acting Antimicrobial Agent Etak 1/22/2014
American Regent, Inc. Expands Promotional Campaign For Iron Deficiency Anemia Drug Injectafer® (Ferric Carboxymaltose Injection) 1/22/2014
Ipsen (IPN.PA) Implements A New Governance In The United States To Prepare For The Launch Of Somatuline® In Oncology 1/22/2014
BioCon Limited (BIOCON.NS) Hits Roche (RHHBY) First, Set To Launch Biosimilar Of Breast Cancer Drug Herceptin 1/21/2014
H. Lundbeck A/S (LUN.CO)'s Brintellix® (Vortioxetine) For The Treatment Of Major Depressive Disorder In Adults Is Now Available In U.S. Pharmacies 1/21/2014
Vectura Group plc (VEC.L)'s AirFluSal® Forspiro® Launched In Denmark 1/20/2014
Seattle Genetics, Inc. (SGEN) Announces ADCETRIS® (Brentuximab Vedotin) Approval In Japan For The Treatment Of Relapsed Or Refractory Hodgkin Lymphoma And Anaplastic Large Cell Lymphoma 1/17/2014
Roche (RHHBY) Resolves U.S. Shortage Of Tamiflu For Children 1/17/2014
Ariad Pharmaceuticals, Inc. (ARIA) Announces The Commercial Availability Of Iclusig (Ponatinib) For Patients With Refractory Philadelphia-Positive Leukemias In The U.S. 1/17/2014
Par Pharmaceutical, Inc. Begins Shipment Of Generic Lanoxin® 1/17/2014
Heritage Pharmaceuticals Announces The Launch Of Prochlorperazine Injection 1/16/2014
Antares Pharma, Inc. (AIS) Announces Availability Of OTREXUP (Methotrexate) Injection For Subcutaneous Use To Treat Rheumatoid Arthritis (RA) And Psoriasis In Adults, And Polyarticular Idiopathic Arthritis (Pjia) In Children 1/15/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Announces Availability Of FAMPYRA® In Ireland To Treat Walking Impairment In Adults With Multiple Sclerosis 1/15/2014
Axxess Pharma, Inc. Announces Launch Of New TapouT Product "TapouT Extreme Muscle" 1/14/2014
CorMedix (CRMD) Expands Neutrolin® Sales With Middle East Distribution Agreements 1/13/2014
Alimera Sciences (ALIM) Ships First ILUVIEN® Orders For U.K. National Health Service Hospitals 1/13/2014